|
 (Health-NewsWire.Net, September 30, 2020 ) The ELISpot and FluoroSpot Assay market is projected to reach USD 287 million by 2023 from USD 135 million in 2018, at a CAGR of 16.2% during the forecast period.Growth in ELISpot and FluoroSpot market is driven by the rising global incidence of chronic...
 (Health-NewsWire.Net, September 30, 2020 ) The Factors such as growth in the companion animal population, rising demand for pet insurance, an increasing number of veterinary practitioners in developed economies, increasing demand for animal-derived food products, and increasing incidence of transboundary...
 (Health-NewsWire.Net, September 30, 2020 ) According to research report the global Genome Editing Market is projected to be valued at USD 3.19 Billion in 2017 and is expected to grow at a CAGR of 14.5% to reach to USD 6.28 Billion by 2022. The key factors propelling the growth of this market are...
 (Health-NewsWire.Net, September 30, 2020 ) The growth of this Injection Pen market is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support.According MarketsandMarkets,...
 (Health-NewsWire.Net, September 30, 2020 ) According to a new market research report “Biological Safety Cabinet Market by Type (Class I, Class II (Type A, Type B), Class III), End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostic & Testing Laboratories, Academic & Research Institution)...
 (Health-NewsWire.Net, September 30, 2020 ) Growth of this market include increasing R&D spending in the pharmaceutical and biopharmaceutical industries and increasing purity requirements among end users of track etched membranes. However, the high cost of production and the limited supply of track...
 (Health-NewsWire.Net, September 30, 2020 ) The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base,...
 (Health-NewsWire.Net, September 30, 2020 ) The major factors that are expected to be driving the pharmacy automation market are the growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population and rising labor cost. On the other hand, reluctance among...
 (Health-NewsWire.Net, September 30, 2020 ) Benefits offered by robotic systems in pharmaceutical manufacturing is a key factor driving the growth of pharmaceutical robots market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021....
 (Health-NewsWire.Net, September 30, 2020 ) The global clinical trial management system (CTMS) market is expected to reach USD 1,065.6 million by 2022 from USD 590.0 million in 2017, at a CAGR of 12.6%. Factors such as significant outsourcing of clinical trial research to CROs, rising number of clinical...
 (Health-NewsWire.Net, September 29, 2020 ) The study involved four major activities in estimating the current size of the sterile filtration market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings,...
 (Health-NewsWire.Net, September 29, 2020 ) The rising prevalence of chronic diseases and the growing number of trauma & injury cases, the rising demand for blood components and growing concerns regarding blood safety, and the favorable reimbursement for apheresis procedures are the major factors...
 (Health-NewsWire.Net, September 29, 2020 ) The factors supporting market growth include the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements & new product launches.The home care settings segment is expected to grow at the highest CAGR during...
 (Health-NewsWire.Net, September 29, 2020 ) The major factors driving the growth of this market include rising technological advancements in fill-finish manufacturing processes, the growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms.The...
 (Health-NewsWire.Net, September 29, 2020 ) The increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations are the key factors driving the growth of this market.Logistics services segment to dominate the clinical...
|
